INOVIQ Ltd (ASX:IIQ)
Australia · Delayed Price · Currency is AUD 0.1600
-0.0100 (-5.88%)
Oct 7, 2026, 2:25 PM AEST
INOVIQ Market Cap
INOVIQ has a market cap or net worth of 22.52 million as of October 7, 2026. That makes INOVIQ the world's #38,847 most valuable public company and #1,064 in Australia. Its market cap has decreased by -49.56% in one year.
Market Cap
22.52M
Enterprise Value
13.46M
Revenue
2.21M
Global Rank
Country Rank
#1,064 Australia
PE Ratio
n/a
ChartMarket Cap Chart
Since June 20, 2016, INOVIQ's market cap has increased from 13.25M to 22.52M, an increase of 70.02%. That is a compound annual growth rate of 5.29%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2026 | 22.52M | -58.71% |
| Dec 31, 2025 | 54.55M | -5.02% |
| Dec 31, 2024 | 57.44M | -6.14% |
| Dec 29, 2023 | 61.19M | 3.91% |
| Dec 30, 2022 | 58.89M | -46.44% |
| Dec 31, 2021 | 109.96M | 102.60% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Australian Clinical Labs | 519.98M |
| Monash IVF Group | 294.17M |
| Healius | 294.09M |
| Cryosite | 56.13M |
| Microba Life Sciences | 33.61M |
| BCAL Diagnostics | 33.55M |
| Rhythm Biosciences | 27.60M |
| Genetic Signatures | 17.94M |